17 results
8-K
EX-2.1
MIRM
Mirum Pharmaceuticals Inc
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
of this Agreement, whenever the context requires: the singular number shall include the plural, and vice versa; the masculine gender shall include … the feminine and neuter genders; the feminine gender shall include the masculine and neuter genders; and the neuter gender shall include masculine
8-K
EX-10.1
6m5eht vt2gh4wp
19 Nov 21
Entry into a Material Definitive Agreement
6:08am
S-3
EX-1.2
tdwg yw3w4
3 Aug 20
Shelf registration
9:00am
DEF 14A
3m6nc
29 Apr 20
Definitive proxy
4:15pm
S-1
EX-10.15
iptcf3x28inbkpx
21 Jun 19
IPO registration
3:24pm
S-1
EX-10.20
a9a4oxn6aycnljf
21 Jun 19
IPO registration
3:24pm
S-1
EX-10.21
pedy30
21 Jun 19
IPO registration
3:24pm
S-1
EX-10.17
soj686q1w50t9
21 Jun 19
IPO registration
3:24pm
DRS
EX-10.21
spe2ewqribha0pqm4q
18 Apr 19
Draft registration statement
12:00am
DRS
EX-10.15
nrkvp2768yr
18 Apr 19
Draft registration statement
12:00am
DRS
EX-10.17
rz2 i2njeo
18 Apr 19
Draft registration statement
12:00am
DRS
EX-10.20
fnu0hgixhcqz twggu
18 Apr 19
Draft registration statement
12:00am
- Prev
- 1
- Next